DIFLUCAN 150MG CAP

Purchase this product now and earn 49 Points!

Description

DIFLUCAN 150MG CAP; fluconazole, antifungals .

ACTIVE-INGREDIENT OF DIFLUCAN 150MG CAP

each hard capsule contains fluconazole 150 mg . Excipient(s) with known effects : each hard capsule also contains 149.123 mg lactose monohydrate .

INDICATION OF DIFLUCAN 150MG CAP

diflucan is indicated in the following fungal infections . Diflucan is indicated in adults for the treatment of : cryptococcal meningitis . Coccidioidomycosis . Invasive candidiais . Mucosal candidiasis including oropharyngeal , oesophageal candidiasis , candiduria and chronic mucocutaneous candidiasis . chronic oral atrophic candidiasis ( denture sore mouth ) if dental hygiene or topical treatment are insufficient . vaginal candidiasis , acute or recurrent , when local therapy is not appropriate . canddidal balanitis when local therapy is not appropriate . dermatomycosis including tinea corporis , tinea cruris , tinea versicolor and dermal candida infections when systemic therapy is indicated . tinea unguinium ( onychomycosis ) when other agents are not considered appropriate . diflucan is indicated in adults for the prophylaxis of : relapse of cryptococcal meningitis in patients with high risk of recurrence . relapse of orophayngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse . to reduce the incidence of recurrent vaginal candidiasis ) 4 or more episodes a year ) . prophylaxis of candidal infections in patients with prolonged neutropenia ( such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic sterm cell transplantation . diflucan is indicated in term newborn infants , infants , toddlers , children , and adolescents aged from 0 to 17 years old : diflucan is used for the treatment of mucosal caddidiasis ( oropharyngeal , oesophageal ) , invasive candidiasis , cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients . diflucan can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reccurrence . therapy may be institued before the results of the cultures and other laboratory studies are known ; however , once these results become available , anti-infective therapy should be adjusted accordingly , consideration should be given to official guidance on the appropriate use of antifungals .

DOSAGE OF DIFLUCAN 150MG CAP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

The should be based on the nature and severity of the fungal infection. Treatment of infections requiring
multiple dosing should be continued until clinical parameters or laboratory tests indicate that active fungal infection has subsided . an inadequate period of treatment may lead to recurrence of active infection . adults : –

OVER-DOSAGE OF DIFLUCAN 150MG CAP

there have been reports of overdose with ddiflucan and hallucination and paranoid have been concomitantly reported . In the event of overdose , symptomatic treatment ( with supportive measures and gastric lavage if necessary ) may be adequate . fluconazole is largely excreted in the urine , forced volume diuresis would propably increase the elimination rate . a three-hour haemodialysis session decreases plasma levels by approximately 50% .

CONTRA-INDICATION OF DIFLUCAN 150MG CAP

hypersensitivity to the active substance , to related azole substances , or to any of the excipients .coadministration of terfenadine is contraindicated in patients receiving diflucan at multiple doses of 400 mg per day or higher based upon results of a multiple dose interaction study . coadministration of other medicinal products known to prolong the QT interval and which aremetabolised via the cytochrome P450 ( CYP) 3A4 such as cisapride , astemizole , pimozide , quinidine and erythromycin are contraindicated in patients receiving fluconazole .

STORAGE OF DIFLUCAN 150MG CAP

store at temperature not exceeding 30 ° C , in a dry place .
PACK OF DIFLUCAN 150MG CAP
carton box containing one (AL/transparent PVC) blister of one hard gelatin capsule+insert.
DIFLUCAN 150MG CAP MANUFACTURED BY
PFIZER EGYPT .

https://www.webmd.com/drugs/2/drug-3780-5052/fluconazole-oral/fluconazole-oral/details

https://www.gardeniapharmacy.com/category/medicine-2/

Additional information

Form

Gender

How to use

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “DIFLUCAN 150MG CAP”

Your email address will not be published. Required fields are marked *

Shopping Cart
Don`t copy text!
Scroll to Top

SPIN TO WIN!

  • Try your lucky to get discount coupon
  • 1 spin per email
  • No cheating
Try Your Luck
Never
Remind later
No thanks